NHWK
Income statement / Annual
Last year (2024), NightHawk Biosciences, Inc.'s total revenue was $6.24 T,
an increase of 104,380,928.37% from the previous year.
In 2024, NightHawk Biosciences, Inc.'s net income was -$32.81 T.
See NightHawk Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$6.24 T |
$5.98 M |
$2.11 M |
$2.95 M |
$3.05 M |
$5.79 M |
$1.52 M |
$341.64 K |
$0.00 |
$0.00 |
| Cost of Revenue |
$3.20 T
|
$6.40 M
|
$691.48 K
|
$12.94 M
|
$13.01 M
|
$16.23 M
|
$8.27 M
|
$9.33 M
|
$116.00 K
|
$5.25 M
|
| Gross Profit |
$3.05 T
|
-$420.03 K
|
$1.42 M
|
-$9.99 M
|
-$9.96 M
|
-$10.44 M
|
-$6.75 M
|
-$8.99 M
|
-$116.00 K
|
-$5.25 M
|
| Gross Profit Ratio |
0.49
|
-0.07
|
0.67
|
-3.39
|
-3.27
|
-1.8
|
-4.44
|
-26.31
|
0
|
0
|
| Research and Development Expenses |
$14.33 T
|
$23.46 M
|
$18.82 M
|
$12.94 M
|
$13.01 M
|
$16.23 M
|
$8.27 M
|
$9.33 M
|
$2.60 M
|
$2.86 M
|
| General & Administrative Expenses |
$0.00
|
$21.13 M
|
$16.83 M
|
$14.93 M
|
$9.43 M
|
$7.03 M
|
$6.37 B
|
$4.14 M
|
$4.36 M
|
$3.98 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$6.36 B
|
$0.00
|
$14.07 M
|
$5.35 M
|
| Selling, General & Administrative Expenses |
$21.57 T
|
$21.13 M
|
$16.83 M
|
$14.93 M
|
$9.43 M
|
$7.03 M
|
$6.37 M
|
$4.14 M
|
$18.43 M
|
$9.33 M
|
| Other Expenses |
$749.25 B
|
$628.45 K
|
-$965.82 K
|
$188.42 K
|
-$25.56 K
|
$117.78 K
|
$224.29 M
|
$670.78 K
|
$0.00
|
$5.35 M
|
| Operating Expenses |
$36.65 T
|
$45.22 M
|
$35.65 M
|
$27.87 M
|
$22.44 M
|
$23.26 M
|
$14.64 M
|
$13.47 M
|
$21.02 M
|
$12.19 M
|
| Cost And Expenses |
$39.84 T
|
$51.62 M
|
$35.65 M
|
$27.87 M
|
$22.44 M
|
$23.26 M
|
$14.64 M
|
$13.47 M
|
$21.02 M
|
$12.19 M
|
| Interest Income |
$22.23 B
|
$987.25 K
|
$815.32 K
|
$566.72 K
|
$431.82 K
|
$265.75 K
|
$22.17 K
|
$31.14 K
|
$66.00 K
|
$40.57 K
|
| Interest Expense |
-$953.17 B
|
$2.82 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$549.40 K
|
$364.00 K
|
$73.35 K
|
| Depreciation & Amortization |
$0.00
|
$4.93 M
|
$4.35 M
|
$3.74 M
|
$2.70 M
|
$237.32 K
|
$134.08 K
|
$132.08 K
|
$116.00 K
|
$66.90 K
|
| EBITDA |
-$34.33 T |
-$40.76 M |
-$31.07 M |
-$22.38 M |
-$18.05 M |
-$16.73 M |
-$12.96 M |
-$12.29 M |
-$20.84 M |
-$12.08 M |
| EBITDA Ratio |
-5.5
|
-6.81
|
-14.71
|
-7.59
|
-5.92
|
-2.89
|
-8.53
|
-35.98
|
0
|
0
|
| Operating Income Ratio |
-5.5
|
-7.64
|
-16.76
|
-8.86
|
-6.8
|
-3.1
|
-8.78
|
-38.42
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
-$1.51 M
|
-$4.38 M
|
-$1.46 M
|
-$944.02 K
|
-$112.40 K
|
-$700.85 K
|
$152.52 K
|
-$100.00 K
|
-$56.00 K
|
| Income Before Tax |
-$34.33 T
|
-$47.15 M
|
-$35.55 M
|
-$26.38 M
|
-$20.34 M
|
-$17.58 M
|
-$13.22 M
|
-$12.97 M
|
-$21.12 M
|
-$12.24 M
|
| Income Before Tax Ratio |
-5.5
|
-7.88
|
-16.82
|
-8.95
|
-6.67
|
-3.03
|
-8.7
|
-37.98
|
0
|
0
|
| Income Tax Expense |
-$1.52 T
|
-$3.29 M
|
-$145.97 K
|
$1.31 M
|
$45.18 K
|
-$985.49 K
|
-$809.54 K
|
$819.34 K
|
-$463.00 K
|
-$381.04 K
|
| Net Income |
-$32.81 T
|
-$43.86 M
|
-$35.40 M
|
-$27.69 M
|
-$20.38 M
|
-$15.73 M
|
-$11.84 M
|
-$12.57 M
|
-$20.30 M
|
-$11.79 M
|
| Net Income Ratio |
-5.26
|
-7.33
|
-16.76
|
-9.39
|
-6.69
|
-2.72
|
-7.79
|
-36.8
|
0
|
0
|
| EPS |
-1304102.05 |
-1.72 |
-1.42 |
-1.18 |
-4.29 |
-6.3 |
-21.56 |
-50.05 |
-177.23 |
-127.84 |
| EPS Diluted |
-1304102.05 |
-1.71 |
-1.42 |
-1.18 |
-4.29 |
-6.3 |
-21.56 |
-50.05 |
-174.92 |
-126.18 |
| Weighted Average Shares Out |
$25.16 M
|
$25.55 M
|
$24.87 M
|
$23.39 M
|
$4.75 M
|
$2.50 M
|
$549.33 K
|
$251.23 K
|
$114.51 K
|
$92.21 K
|
| Weighted Average Shares Out Diluted |
$25.16 M
|
$25.61 M
|
$24.91 M
|
$23.39 M
|
$4.75 M
|
$2.50 M
|
$549.33 K
|
$251.23 K
|
$116.02 K
|
$93.43 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
